Published in Gut on April 01, 2000
Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut (2007) 1.57
Helicobacter pylori infection and the risks of Barrett's oesophagus: a population-based case-control study. Int J Cancer (2011) 1.00
Helicobacter pylori and gastroesophageal reflux disease: a case-control study. Helicobacter (2008) 0.97
Autoimmune atrophic gastritis--pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol (2013) 0.96
Association of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection. World J Gastroenterol (2010) 0.95
Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma. World J Gastroenterol (2005) 0.88
Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study. Gut (2002) 0.87
Biomarkers in various types of atrophic gastritis and their diagnostic usefulness. Dig Dis Sci (2005) 0.86
Serum pepsinogen concentrations as a measure of gastric acid secretion in Helicobacter pylori-negative and -positive Japanese subjects. J Gastroenterol (2005) 0.82
Effect of some natural products either alone or in combination on gastritis induced in experimental rats. Dig Dis Sci (2008) 0.81
Atrophic gastritis: deficient complex I of the respiratory chain in the mitochondria of corpus mucosal cells. J Gastroenterol (2008) 0.79
Does gastric atrophy exist in children? World J Gastroenterol (2006) 0.79
Relation of atrophic gastritis with Helicobacter pylori-CagA(+) and interleukin-1 gene polymorphisms. World J Gastroenterol (2008) 0.79
Age-dependent accuracy of Helicobacter pylori antibody assays for adults, with special emphasis on atrophic gastritis. Clin Diagn Lab Immunol (2004) 0.79
Clinical usefulness of the serological gastric biopsy for the diagnosis of chronic autoimmune gastritis. Clin Dev Immunol (2012) 0.78
ATP4A autoimmunity and Helicobacter pylori infection in children with type 1 diabetes. Clin Exp Immunol (2014) 0.76
Proton pump inhibitors relieve and prevent symptoms related to gastric acidity after esophagectomy. World J Surg (2008) 0.75
Correlation of serum anti-helicobacter pylori immunoglobulin a (IgA) with histological parameters of chronic gastritis in ibadan, Nigeria. Ann Ib Postgrad Med (2012) 0.75
Gastritis induced by Helicobacter pylori infection in experimental rats. Dig Dis Sci (2010) 0.75
Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet (1983) 23.90
Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res (1995) 11.07
Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst (1995) 6.07
The Sydney System: histological division. J Gastroenterol Hepatol (1991) 5.49
Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut (1997) 4.70
Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet (1992) 4.54
Long-term sequelae of Helicobacter pylori gastritis. Lancet (1995) 4.26
Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut (1997) 3.39
Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology (1991) 3.38
Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol (1995) 3.23
A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis (1973) 2.85
Helicobacter pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology (1991) 2.57
Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut (1993) 2.47
The gastric H+,K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology (1998) 1.26
Pernicious anaemia and Campylobacter like organisms; is the gastric antrum resistant to colonisation? Gut (1989) 1.17
Helicobacter pylori infection is the major risk factor for atrophic gastritis. Am J Gastroenterol (1996) 1.15
Role of Helicobacter pylori in the pathogenesis of atrophic gastritis. Scand J Gastroenterol Suppl (1997) 1.14
Evaluation of Pyloriset Screen, a rapid whole-blood diagnostic test for Helicobacter pylori infection. J Clin Microbiol (1998) 1.14
Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status. Am J Gastroenterol (1998) 1.14
Classification principles and genetics of chronic gastritis. Scand J Gastroenterol Suppl (1987) 1.04
Positive correlation between H,K-adenosine triphosphatase autoantibodies and Helicobacter pylori antibodies in patients with pernicious anemia. Scand J Gastroenterol (1994) 1.04
Pernicious anemia and Helicobacter pylori infection in Japan: evaluation in a country with a high prevalence of infection. Am J Gastroenterol (1995) 1.02
An appraisal of tests for severe atrophic gastritis in relatives of patients with pernicious anemia. Dig Dis Sci (1979) 0.97
Gastric morphology, function, and immunology in first-degree relatives of probands with pernicious anemia and controls. Scand J Gastroenterol (1979) 0.95
Tissue antibodies in malignant and benign urogenital disease. Int J Cancer (1977) 0.82
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet (1997) 7.59
Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologists. Cancer (2000) 4.55
Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet (1992) 4.54
Relationship of leisure-time physical activity and mortality: the Finnish twin cohort. JAMA (1998) 4.35
Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer (1998) 3.98
Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66
Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology (1991) 3.38
Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med (1977) 3.32
Ulex europaeus I lectin as a marker for vascular endothelium in human tissues. Lab Invest (1982) 3.29
Direct detection of Mycobacterium tuberculosis complex in respiratory specimens by Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test and Roche Amplicor Mycobacterium Tuberculosis Test. J Clin Microbiol (1995) 3.28
Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res (1997) 2.99
Diagnosis of twin zygosity by mailed questionnaire. Hum Hered (1978) 2.85
Comparison of manual Amplicor PCR, Cobas Amplicor PCR, and LCx assays for detection of Chlamydia trachomatis infection in women by using urine specimens. J Clin Microbiol (1997) 2.73
Stability of related human and chicken Campylobacter jejuni genotypes after passage through chick intestine studied by pulsed-field gel electrophoresis. Appl Environ Microbiol (1999) 2.38
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes (1999) 2.36
Snoring as a risk factor for ischaemic heart disease and stroke in men. Br Med J (Clin Res Ed) (1987) 2.31
The Finnish Twin Registry: formation and compilation, questionnaire study, zygosity determination procedures, and research program. Prog Clin Biol Res (1978) 2.24
Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol (2003) 2.23
Demonstration of an intracellular copper-binding protein by orcein staining in long-standing cholestatic liver diseases. Gut (1976) 2.09
Snoring as a risk factor for hypertension and angina pectoris. Lancet (1985) 2.09
Knee osteoarthritis in former runners, soccer players, weight lifters, and shooters. Arthritis Rheum (1995) 2.01
White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke (1995) 2.01
Prognosis of severe brain injury. Acta Neurol Scand (1970) 1.98
Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases. J Clin Pathol (1984) 1.98
Campylobacter pylori in a sample of Finnish population: relations to morphology and functions of the gastric mucosa. Gut (1988) 1.98
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94
Genetic influences on use and abuse of alcohol: a study of 5638 adult Finnish twin brothers. Alcohol Clin Exp Res (1987) 1.93
Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer (1985) 1.89
Detection of Chlamydia trachomatis infections in women by Amplicor PCR: comparison of diagnostic performance with urine and cervical specimens. J Clin Microbiol (1996) 1.89
Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors: circulating levels and tissue localization. Cancer (1978) 1.84
Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins. Lab Invest (1983) 1.82
A three-year study of Campylobacter jejuni genotypes in humans with domestically acquired infections and in chicken samples from the Helsinki area. J Clin Microbiol (2000) 1.81
Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients. J Clin Oncol (1997) 1.80
Chlamydial endometritis. J Clin Pathol (1985) 1.80
Lone atrial fibrillation in vigorously exercising middle aged men: case-control study. BMJ (1998) 1.77
Detection and typing of Campylobacter jejuni and Campylobacter coli and analysis of indicator organisms in three waterborne outbreaks in Finland. Appl Environ Microbiol (2003) 1.75
Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland) Cancer Causes Control (2000) 1.75
Evaluation of the Gen-Probe Chlamydia trachomatis transcription-mediated amplification assay with urine specimens from women. J Clin Microbiol (1997) 1.74
Biogenesis of podocalyxin--the major glomerular sialoglycoprotein--in the newborn rat kidney. Eur J Cell Biol (1989) 1.74
Osteoarthritis of weight bearing joints of lower limbs in former élite male athletes. BMJ (1994) 1.72
Detection of Mycobacterium tuberculosis complex in sputum specimens by the automated Roche Cobas Amplicor Mycobacterium Tuberculosis Test. J Clin Microbiol (1998) 1.68
Multifactorial primary prevention of cardiovascular diseases in middle-aged men. Risk factor changes, incidence, and mortality. JAMA (1985) 1.66
Gastrointestinal complaints and diagnosis in children: a population-based study. Acta Paediatr (2004) 1.66
Microbiological and histopathological findings in acute pelvic inflammatory disease. Br J Obstet Gynaecol (1987) 1.65
An acid extract as a common antigen in Campylobacter coli and Campylobacter jejuni strains. J Clin Microbiol (1983) 1.65
OLGA staging for gastritis: a tutorial. Dig Liver Dis (2008) 1.64
Colonic motor and myoelectrical activity: a comparative study of normal subjects, psychoneurotic patients, and patients with irritable bowel syndrome. Gastroenterology (1981) 1.64
Serum CA 125 in acute pelvic inflammatory disease. Br J Obstet Gynaecol (1989) 1.62
Typing of human Campylobacter jejuni isolates in Finland by pulsed-field gel electrophoresis. J Clin Microbiol (1998) 1.59
Increase of allergen-specific immunoglobulin E antibodies from 1973 to 1994 in a Finnish population and a possible relationship to Helicobacter pylori infections. Clin Exp Allergy (2002) 1.59
Questionable specificity of lipid antigen in the Mycoplasma pneumoniae complement fixation test in patients with extrapulmonary manifestations. J Infect (1981) 1.58
Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis. J Exp Med (1992) 1.56
Relationship of skeletal muscle fiber type to serum high density lipoprotein cholesterol and apolipoprotein A-I levels. Atherosclerosis (1991) 1.56
Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. Br J Cancer (1984) 1.56
Expression of vimentin and cytokeratin types of intermediate filament proteins in developing and adult human kidneys. Lab Invest (1984) 1.56
Gastric metaplasia and chronic inflammation at the duodenal bulb mucosa. Dig Liver Dis (2003) 1.55
Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children. J Infect Dis (1980) 1.53
Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study. Scand J Gastroenterol (1991) 1.53
Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa. Infect Immun (1997) 1.52
Real-time PCR for detection and quantitation of hepatitis B virus DNA. J Med Virol (2001) 1.52
Acute childhood asthma in Finland: a retrospective review of hospital admissions from 1976 to 1995. Pediatr Allergy Immunol (2000) 1.50
Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect (1997) 1.49
CSF and MRI findings in patients with acute herpes zoster. Neurology (1998) 1.49
Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol (1996) 1.48
Gastric cancer associated structure in mucus glycoproteins shown as a clinically useful marker. Gut (1991) 1.48
Adhesion molecule expression in symptomatic and asymptomatic carotid stenosis. Neurology (2003) 1.47
Intestinal metaplasia with colonic-type sulphomucins in the gastric mucosa; its association with gastric carcinoma. Acta Pathol Microbiol Scand A (1980) 1.47
Apoptosis in different compartments of antrum and corpus mucosa in chronic Helicobacter pylori gastritis. An 18-year follow-up study. Scand J Gastroenterol (2001) 1.45
Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia. Am J Gastroenterol (2001) 1.45
Lectins as fluorescence microscopic markers for saccharides in the human kidney. Lab Invest (1981) 1.45
Ulex europaeus I lectin as a marker for tumors derived from endothelial cells. Am J Clin Pathol (1983) 1.44
Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis (2006) 1.44
Evidence that cagA(+) Helicobacter pylori strains are disappearing more rapidly than cagA(-) strains. Gut (2002) 1.43
Risk factors for cervical atherosclerosis in patients with transient ischemic attack or minor ischemic stroke. Stroke (1993) 1.42
Anatomic sites of upper genital tract infection. Obstet Gynecol (1985) 1.41
Follow-up of Helicobacter pylori positive gastritis and argyrophil cells pattern during the natural course of gastric ulcer. Helicobacter (1998) 1.41
Nephrin localizes at the podocyte filtration slit area and is characteristically spliced in the human kidney. Am J Pathol (1999) 1.40
Familial herpes encephalitis. Lancet (1995) 1.40
Mycoplasmas and leukaemia. Res Virol (1992) 1.39
Heymann nephritis induced by kidney brush border glycoproteins. Lab Invest (1980) 1.39
Involvement of lipid rafts in nephrin phosphorylation and organization of the glomerular slit diaphragm. Am J Pathol (2001) 1.39
The long-term effects of physical loading and exercise lifestyles on back-related symptoms, disability, and spinal pathology among men. Spine (Phila Pa 1976) (1995) 1.38
Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines. Acta Paediatr (1999) 1.38
Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology (Oxford) (2002) 1.38
Hostility as a risk factor for mortality and ischemic heart disease in men. Psychosom Med (1988) 1.38
Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample. Cancer (1983) 1.36
Transferrin as a fetal growth factor: acquisition of responsiveness related to embryonic induction. Proc Natl Acad Sci U S A (1983) 1.35
Trends and availability of suicide methods in Finland. Proposals for restrictive measures. Br J Psychiatry (1995) 1.35
Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up. Am J Epidemiol (1993) 1.32
Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cancer (2003) 1.30
Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double-blind controlled study. Scand J Gastroenterol (1982) 1.30
Gastric polyps; their morphological and endoscopical characteristics and relation to gastric carcinoma. Acta Pathol Microbiol Immunol Scand A (1982) 1.29
Early and late posttraumatic seizures in traumatic brain injury rehabilitation patients: brain injury factors causing late seizures and influence of seizures on long-term outcome. Epilepsia (1999) 1.29
Mycoplasma hominis in nonspecific vaginitis. Sex Transm Dis (1984) 1.29
Fecal bacteriology and reservoir ileitis in patients operated on for ulcerative colitis. Dis Colon Rectum (1988) 1.29
HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomatis-related tubal factor infertility: a case-control study. Hum Reprod (2002) 1.29